The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission released ...
Abby Jones’ first stop of the day delivering medication was the home of 90-year-old Sarah Campbell Kier. “Come in!” yelled ...
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...
The Iowa Pharmacy Association is calling for reform from Iowa lawmakers after 29 pharmacies closed last year, including some ...
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
A new FTC report blames Pharmacy Benefit Managers for marking up specialty drug prices, profiting $7.3 billion from cancer ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
Pharmacy advocate groups are teaming up with lawmakers to get new legislation passed to stop monopolistic behaviors from ...
That reality is the very reason that's prompting lawmakers to take action against Pharmacy Benefit Managers (PBMs) in hopes of preventing further economic strain on communities. A press conference ...